Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Nutex Health Inc.

    NASDAQ: NUTX · Real-Time Price · USD
    122.79
    -2.14 (-1.71%)
    At close: Jun 13, 2025, 3:59 PM
    123.30
    0.42%
    Pre-market: Jun 16, 2025, 06:24 AM EDT

    Nutex Health Statistics

    Share Statistics

    Nutex Health has 5.56M shares outstanding. The number of shares has increased by -89.06% in one year.

    Shares Outstanding

    n/a
    		 5.56M

    Shares Change (YoY)

    n/a
    		 -89.06%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 17.78%

    Shares Floating

    n/a
    		 3.54M

    Failed to Deliver (FTD) Shares

    n/a
    		 136

    FTD / Avg. Volume

    n/a
    		 0.1%

    Short Selling Information

    The latest short interest is 213.91K, so 3.84% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 213.91K

    Short % of Shares Out

    n/a
    		 3.84%

    Short % of Float

    n/a
    		 5.95%

    Short Ratio (days to cover)

    n/a
    		 1.71

    Valuation Ratios

    The PE ratio is 3.1 and the forward PE ratio is 10.45. Nutex Health's PEG ratio is -0.02.

    PE Ratio

    n/a
    		 3.1

    Forward PE

    n/a
    		 10.45

    PS Ratio

    n/a
    		 0.34

    Forward PS

    n/a
    		 0.9

    PB Ratio

    n/a
    		 1.1

    P/FCF Ratio

    n/a
    		 7.75

    PEG Ratio

    n/a
    		 -0.02
    Financial Ratio History

    Enterprise Valuation

    Nutex Health has an Enterprise Value (EV) of 458.34M.

    EV / Sales

    n/a
    		 0.95

    EV / EBITDA

    n/a
    		 3.08

    EV / EBIT

    n/a
    		 19.8

    EV / FCF

    n/a
    		 21.98

    Financial Position

    The company has a current ratio of 2.08, with a Debt / Equity ratio of 2.33.

    Current Ratio

    n/a
    		 2.08

    Quick Ratio

    n/a
    		 2.06

    Debt / Equity

    n/a
    		 2.33

    Debt / EBITDA

    n/a
    		 2.29

    Debt / FCF

    n/a
    		 16.32

    Interest Coverage

    n/a
    		 6.55

    Financial Efficiency

    Return on Equity is 35.65% and Return on Invested Capital is 20.91%.

    Return on Equity

    n/a
    		 35.65%

    Return on Assets

    n/a
    		 7.96%

    Return on Invested Capital

    n/a
    		 20.91%

    Revenue Per Employee

    n/a
    		 $599,935.79

    Profits Per Employee

    n/a
    		 $65,223.96

    Employee Count

    n/a
    		 800

    Asset Turnover

    n/a
    		 0.73

    Inventory Turnover

    n/a
    		 99.55

    Taxes

    Income Tax

    n/a
    		 14.48M

    Effective Tax Rate

    n/a
    		 13.19%

    Stock Price Statistics

    The stock price has increased by 2178.11% in the last 52 weeks. The beta is 2.15, so Nutex Health's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.15

    52-Week Price Change

    n/a
    		 2178.11%

    50-Day Moving Average

    n/a
    		 133.23

    200-Day Moving Average

    n/a
    		 60.47

    Relative Strength Index (RSI)

    n/a
    		 40.31

    Average Volume (20 Days)

    n/a
    		 136,876

    Income Statement

    In the last 12 months, Nutex Health had revenue of 479.95M and earned 52.18M in profits. Earnings per share was 10.23.

    Revenue

    n/a
    		 479.95M

    Gross Profit

    n/a
    		 196.26M

    Operating Income

    n/a
    		 130.62M

    Net Income

    n/a
    		 52.18M

    EBITDA

    n/a
    		 148.65M

    EBIT

    n/a
    		 129.68M

    Earnings Per Share (EPS)

    n/a
    		 10.23
    Full Income Statement

    Balance Sheet

    The company has 43.58M in cash and 340.3M in debt, giving a net cash position of -296.72M.

    Cash & Cash Equivalents

    n/a
    		 43.58M

    Total Debt

    n/a
    		 340.3M

    Net Cash

    n/a
    		 -296.72M

    Retained Earnings

    n/a
    		 -356.89M

    Total Assets

    n/a
    		 761.92M

    Working Capital

    n/a
    		 224.95M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 23.15M and capital expenditures -2.3M, giving a free cash flow of 20.85M.

    Operating Cash Flow

    n/a
    		 23.15M

    Capital Expenditures

    n/a
    		 -2.3M

    Free Cash Flow

    n/a
    		 20.85M

    FCF Per Share

    n/a
    		 4.09
    Full Cash Flow Statement

    Margins

    Gross margin is 40.89%, with operating and profit margins of 27.22% and 10.87%.

    Gross Margin

    n/a
    		 40.89%

    Operating Margin

    n/a
    		 27.22%

    Pretax Margin

    n/a
    		 22.87%

    Profit Margin

    n/a
    		 10.87%

    EBITDA Margin

    n/a
    		 30.97%

    EBIT Margin

    n/a
    		 27.22%

    FCF Margin

    n/a
    		 4.34%

    Dividends & Yields

    NUTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 32.29%

    FCF Yield

    n/a
    		 12.9%
    Dividend Details

    Analyst Forecast

    The average price target for NUTX is $262.5, which is 113.8% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $262.5

    Price Target Difference

    n/a
    		 113.8%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $51.15

    Lynch Upside

    n/a
    		 -58.34%

    Graham Number

    n/a
    		 81.27

    Graham Upside

    n/a
    		 -33.81%

    Stock Splits

    The last stock split was on Jul 3, 2024. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jul 3, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 2.54

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist